Joseph Sabat, MD
Vascular Surgery · Tucson, AZNPI 1538426069
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (57.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Angiodynamics, Inc. at 57.9% of the total. 2025 is the largest year on record at $16,668, 4.6 times the $3,589 reported in 2019.
Across 290 payments — averaging $164.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$28K
- Inari Medical, Inc.$6K
- Silk Road Medical, Inc.$2K
- Boston Scientific$2K
- Medtronic$1K
- Abbott$1K
- plus $7K from 35 others
Across 28 payments — averaging $3287.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bolton Medical Inc$38K
- Medtronic$26K
- Abbott$18K
- Boston Scientific$10K
What the payments were for
- Consulting fees$5,02511%
- Grants$1,3033%
- Travel & lodging$1,5383%
- Food & beverage$12,16926%
- Education$1220%
- Other$27,50058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 3 | $27,580 |
| Inari Medical, Inc. | 36 | $6,342 |
| Silk Road Medical, Inc. | 24 | $2,435 |
| Boston Scientific | 28 | $2,124 |
| Medtronic(2 entities) | 9 | $1,381 |
| Abbott | 49 | $1,042 |
| W. L. Gore & Associates, Inc. | 23 | $914 |
| Bard Peripheral Vascular, Inc. | 17 | $832 |
| Cook Medical LLC | 12 | $769 |
| Philips North America LLC | 3 | $737 |
| Bolton Medical Inc | 7 | $562 |
| Abiomed | 3 | $370 |
| Stryker | 5 | $299 |
| Intact Vascular, Inc. | 2 | $259 |
| Smith+Nephew | 11 | $233 |
| Terumo Medical Corporation | 3 | $231 |
| Johnson & Johnson | 12 | $200 |
| Edwards Lifesciences | 3 | $194 |
| Pfizer | 2 | $131 |
| Baxter Healthcare | 1 | $125 |
| Tactile Systems Technology Inc | 1 | $124 |
| Cvrx, Inc. | 5 | $119 |
| Recor Medical Inc | 1 | $82 |
| Integra Lifesciences Corporation | 4 | $69 |
| Penumbra, Inc. | 2 | $51 |
| Endologix LLC | 2 | $48 |
| Organogenesis Inc. | 3 | $47 |
| Shockwave Medical, Inc | 2 | $45 |
| BD | 2 | $45 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $43 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $41 |
| Surmodics, Inc. | 1 | $34 |
| Cardiva Medical, Inc. | 2 | $29 |
| Getinge USA Sales, LLC | 1 | $25 |
| Biocompatibles, Inc. | 1 | $24 |
| GSK | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $16 |
| Misonix Inc | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
| Advanced Oxygen Therapy Inc. | 1 | $8 |
| ETS Wound Care LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$27,500
- FLOWTRIEVER CATHETER, S$6,428
- CT THROMBECTOMY SYSTEM KIT$4,669
- ENROUTE Transcarotid Neuroprotection System$2,295
- ENHANCE Transcarotid Peripheral Access Kit$1,533
- ENROUTE Transcarotid Stent System$1,382
- ENROUTE 0.014 Guidewire$1,382
- Endurant$1,137
- WALLSTENT$900
- GENERAL CATHETERS$900
- ANGIOJET$900
- ENROUTE Transcarotid Stent$792
- IGT D Peripheral$536
- FlowTriever$454
- ClotTriever$454
- Impella$370
- Grafts$270
- Tack Endovascular System$259
- ENROUTE .014 Guidewire$152
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$151
How this compares
$47,658 in reported general payments places this provider in the 85th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $80,679 |
| XareltoRivaroxaban | 45 | $50,378 |
| SantylCollagenase Clostridium Hist. | 15 | $5,022 |
| Cilostazol | 96 | $2,569 |
| ClopidogrelClopidogrel Bisulfate | 181 | $1,899 |
| Atorvastatin Calcium | 81 | $590 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $131 | $80,67981 claims |
| Johnson & JohnsonXarelto | $200 | $50,37845 claims |
| Smith+NephewSantyl | $233 | $5,02215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Tucson
- Joshua BaldermanTucson$135K
- John PacanowskiTucson$85K
- Bernardo MendozaTucson$33K
- Federico YanquezTucson$31K
- Christopher ComptonTucson$27K
- Matthew NamannyTucson$25K
- Lauren BeliveauTucson$24K
- Eric BerensTucson$19K
- Layla LucasTucson$16K
- Codyjo KraemerTucson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.